VeriMomsodium chitosan caprylamide hydroxypropylsulfonate est-il sûr pendant la grossesse ?
No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment indicating reproductive hazard was found. No peer‑reviewed reproductive or developmental toxicity data were identified for this specific chitosan derivative. As a polymeric chitosan derivative, it is considered to have negligible dermal absorption for adults, supporting a default 'no evidence of reproductive hazard' (CIR/SCCS default). Sources reviewed: ECHA Annex VI, PubChem/CosIng entries where available, PubMed (no reproductive studies), CIR/SCCS absence.
Related ingredients
Frequently asked questions
- sodium chitosan caprylamide hydroxypropylsulfonate est-il sûr pendant la grossesse ?
- No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment indicating reproductive hazard was found. No peer‑reviewed reproductive or developmental toxicity data were identified for this specific chitosan derivative. As a polymeric chitosan derivative, it is considered to have negligible dermal absorption for adults, supporting a default 'no evidence of reproductive hazard' (CIR/SCCS default). Sources reviewed: ECHA Annex VI, PubChem/CosIng entries where available, PubMed (no reproductive studies), CIR/SCCS absence.
- sodium chitosan caprylamide hydroxypropylsulfonate est-il sûr pendant l'allaitement ?
- No evidence of reproductive or lactation toxicity; no data suggesting systemic absorption in adults or transfer into breast milk. No harmonised CLP flags or CIR/SCCS concerns were identified. Therefore default low hazard and negligible exposure for breastfeeding mothers from topical cosmetic use.
- sodium chitosan caprylamide hydroxypropylsulfonate est-il sûr pour la peau de bébé ?
- No infant‑specific reproductive or systemic toxicity data were identified. The ingredient is a high‑molecular‑weight chitosan derivative and likely shows limited skin penetration, but infant skin barrier immaturity and higher surface‑area‑to‑weight justify an exposure score increased by +1 relative to adults. No evidence was found to increase hazard or mechanism scores for infants.
- Comment VeriMom évalue-t-il sodium chitosan caprylamide hydroxypropylsulfonate ?
- VeriMom évalue sodium chitosan caprylamide hydroxypropylsulfonate à 100/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à sodium chitosan caprylamide hydroxypropylsulfonate pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à sodium chitosan caprylamide hydroxypropylsulfonate basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.